IGF1 and Alzheimer disease: Actions of IGF-I on Aβ handling may be related to diet influences on AD pathology; therefore, cellular sites of IGF-I interaction may constitute new druggable targets, through, for example, potentiating the passage of circulating IGF-I into the brain across the BBB.